![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZFP14 |
Gene summary for ZFP14 |
![]() |
Gene information | Species | Human | Gene symbol | ZFP14 | Gene ID | 57677 |
Gene name | ZFP14 zinc finger protein | |
Gene Alias | ZNF531 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q9HCL3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57677 | ZFP14 | HCC1_Meng | Human | Liver | HCC | 3.92e-37 | -4.37e-02 | 0.0246 |
57677 | ZFP14 | HCC2_Meng | Human | Liver | HCC | 1.04e-05 | -1.57e-02 | 0.0107 |
57677 | ZFP14 | cirrhotic1 | Human | Liver | Cirrhotic | 6.04e-04 | 1.15e-01 | 0.0202 |
57677 | ZFP14 | HCC1 | Human | Liver | HCC | 7.86e-19 | 2.93e+00 | 0.5336 |
57677 | ZFP14 | HCC2 | Human | Liver | HCC | 1.36e-25 | 2.39e+00 | 0.5341 |
57677 | ZFP14 | HCC5 | Human | Liver | HCC | 2.13e-16 | 1.92e+00 | 0.4932 |
57677 | ZFP14 | male-WTA | Human | Thyroid | PTC | 3.17e-03 | 8.66e-02 | 0.1037 |
57677 | ZFP14 | PTC01 | Human | Thyroid | PTC | 1.26e-06 | 1.58e-01 | 0.1899 |
57677 | ZFP14 | PTC04 | Human | Thyroid | PTC | 1.49e-07 | 1.48e-01 | 0.1927 |
57677 | ZFP14 | PTC05 | Human | Thyroid | PTC | 6.20e-13 | 4.66e-01 | 0.2065 |
57677 | ZFP14 | PTC06 | Human | Thyroid | PTC | 3.59e-18 | 3.74e-01 | 0.2057 |
57677 | ZFP14 | PTC07 | Human | Thyroid | PTC | 1.31e-19 | 3.08e-01 | 0.2044 |
57677 | ZFP14 | ATC12 | Human | Thyroid | ATC | 1.45e-02 | 1.19e-01 | 0.34 |
57677 | ZFP14 | ATC13 | Human | Thyroid | ATC | 2.12e-43 | 7.29e-01 | 0.34 |
57677 | ZFP14 | ATC1 | Human | Thyroid | ATC | 4.00e-02 | 1.41e-01 | 0.2878 |
57677 | ZFP14 | ATC4 | Human | Thyroid | ATC | 3.04e-06 | 1.62e-01 | 0.34 |
57677 | ZFP14 | ATC5 | Human | Thyroid | ATC | 9.23e-50 | 7.60e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZFP14 | BAS | Oral cavity | NEOLP | RARB,LOXL1,PRR16, etc. | 0.00e+00 | ![]() |
ZFP14 | GRA | Oral cavity | NEOLP | RARB,LOXL1,PRR16, etc. | 0.00e+00 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZFP14 | SNV | Missense_Mutation | c.1000C>A | p.His334Asn | p.H334N | Q9HCL3 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | rs778843600 | c.323N>T | p.Arg108Ile | p.R108I | Q9HCL3 | protein_coding | tolerated(0.36) | benign(0.245) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | c.538A>G | p.Thr180Ala | p.T180A | Q9HCL3 | protein_coding | tolerated(1) | benign(0) | TCGA-D1-A16Y-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | novel | c.330N>C | p.Lys110Asn | p.K110N | Q9HCL3 | protein_coding | tolerated(0.06) | benign(0.276) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | novel | c.1163G>T | p.Arg388Ile | p.R388I | Q9HCL3 | protein_coding | deleterious(0.01) | possibly_damaging(0.675) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
ZFP14 | SNV | Missense_Mutation | novel | c.1252N>A | p.His418Asn | p.H418N | Q9HCL3 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | novel | c.575N>T | p.Arg192Ile | p.R192I | Q9HCL3 | protein_coding | deleterious(0.01) | probably_damaging(0.983) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | c.109G>A | p.Glu37Lys | p.E37K | Q9HCL3 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-EY-A1GS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | taxol | PD | |
ZFP14 | SNV | Missense_Mutation | novel | c.98N>G | p.Asp33Gly | p.D33G | Q9HCL3 | protein_coding | deleterious(0) | possibly_damaging(0.905) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
ZFP14 | SNV | Missense_Mutation | novel | c.644N>C | p.Leu215Pro | p.L215P | Q9HCL3 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-PG-A917-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |